69545-39-7Relevant articles and documents
Preparation method of letrozole
-
Paragraph 0032-0033; 0035-0036; 0038-0039; 0040-0041, (2021/11/10)
To the method, a continuous flow chemical technology is adopted to prepare the key intermediate, and the temperature of the reaction is accurately controlled. The content of triazole isomeric impurities 4 - [α - (4 - cyanophenyl) -1 - (1, 3, 4 - triazolyl) methyl] - benzonitrile is reduced, so that repeated recrystallization is avoided, the yield is improved, the total yield is 44% more than 67%, and the cost is saved.
Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors
Doiron, Jeremie,Soultan, Al Haliffa,Richard, Ryan,Toure, Mamadou Mansour,Picot, Nadia,Richard, Remi,Cuperlovic-Culf, Miroslava,Robichaud, Gilles A.,Touaibia, Mohamed
experimental part, p. 4010 - 4024 (2011/10/30)
A series of bis- and mono-benzonitrile or phenyl analogues of letrozole 1, bearing (1,2,3 and 1,2,5)-triazole or imidazole, were synthesized and screened for their anti-aromatase activities. The unsubstituted 1,2,3-triazole 10a derivative displayed inhibitory activity comparable with that of the aromatase inhibitor, letrozole 1. Compound 10a, bearing a 1,2,3-triazole, is also 10000-times more tightly binding than the corresponding analogue 25 bearing a 1,2,5-triazole, which confirms the importance of a nitrogen atom at position 3 or 4 of the 5-membered ring needed for high activity. The effect on human epithelial adrenocortical carcinoma cell line (H295R) proliferation was also evaluated. The compound 10j (IC50 = 4.64 μM), a letrozole 1 analogue bearing para-cyanophenoxymethylene-1,2,3-triazole decreased proliferation rates of H295R cells by 76 and 99% in 24 and 72 h respectively. Computer calculations, using quantum ab initio structures, suggest a possible correlation between anti-aromatase activity and the distance between the nitrogen in position 3 or 4 of triazole nitrogen and the cyano group nitrogen.
A METHOD OF MANUFACTURE OF LETROZOLE
-
Page/Page column 9, (2008/06/13)
A novel and convenient method of manufacture of letrozole of formula (I) is described. Letrozole is an aromatase inhibitor drug used in the treatment of postmenopausal breast cancer.